GLPG
Galapagos N.V.
NASDAQ · Healthcare · Biotechnology · BE
$27.98
+1.71%Margins
Gross margin
98.0%
EBITDA margin
19.7%
EBIT margin
37.5%
Net margin
46.8%
FCF margin
-29.2%
15.0%
Return on equity
14.5%
Return on assets
12.0%
Return on invested capital
0.31x
Asset turnover
-$343.9M
Cash from operations
$53
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026